1h Free Analyst Time
The autoimmune drugs market is forecasted to grow by USD 33.21 billion during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong R&D pipeline, targeted therapeutic mechanism of biologics, and introduction of affordable biosimilars.
The autoimmune drugs market is segmented as below:
- By Therapy Area
- Rheumatoid arthritis
- Multiple sclerosis
- Psoriasis
- Inflammatory bowel disease
- Others
- By Distribution Channel
- Hospital
- Pharmacy
- Drug store/Retail pharmacy
- Online
- By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the autoimmune drugs market covers the following areas:
- Autoimmune drugs market sizing
- Autoimmune drugs market forecast
- Autoimmune drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Therapy Area
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global autoimmune drugs market: AbbVie Inc., AdvaCare Pharma, Amgen Inc., AstraZeneca PLC, Bristol Myers Squibb Co., Cardinal Health Inc., Delphis Pharmaceutical India, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson and Johnson Services Inc., Medexus Pharmaceuticals Inc., Parvus Therapeutics Inc., Prometheus Laboratories, Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Wellona Pharma.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is reduction in cost of autoimmune drugs."
According to the report, one of the major drivers for this market is the strong R&D pipeline.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- AdvaCare Pharma
- Amgen Inc.
- AstraZeneca Plc
- Bristol Myers Squibb Co.
- Cardinal Health Inc.
- Delphis Pharmaceutical India
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals Plc
- Johnson and Johnson Services Inc.
- Medexus Pharmaceuticals Inc.
- Parvus Therapeutics Inc.
- Prometheus Laboratories
- Regeneron Pharmaceuticals Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Wellona Pharma
